Source: http://health.yahoo.net/news/s/nm/astra-says-looks-at-everything-silent-on-amylin
Tuesday, 24 April 2012
Astra says looks at "everything", silent on Amylin
LONDON (Reuters) - AstraZeneca, which plans to buy Ardea Biosciences for $1.26 billion, is also looking at a range of other biotech assets - but its research head would not be drawn on interest in Amylin Pharmaceuticals. Amylin has started reachin...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.